Restless legs syndrome: Diagnosis and review of management options

Neuropsychiatric Disease and Treatment

Volumn 2, Issue 2, 2006, Pages 155-164

  Byrne, Ruth ^b,c   Sinha, Smita ^b   Chaudhuri, K Ray ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dopaminergic; Ekbom's syndrome; Periodic limb movement; Restless legs syndrome

Indexed keywords

AMANTADINE; APOMORPHINE; BROMOCRIPTINE; CABERGOLINE; CAFFEINE; CARBAMAZEPINE; DIHYDROERGOCRYPTINE; DOMPERIDONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; ETIRACETAM; GABAPENTIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LEVODOPA; LITHIUM; METOCLOPRAMIDE; MIANSERIN; NEUROLEPTIC AGENT; ORPHENADRINE; OXYCODONE; PERGOLIDE; PIRIBEDIL; PLACEBO; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE; SUMANIROLE; TETRACYCLINE; UNINDEXED DRUG;

CAUCASIAN; CLINICAL TRIAL; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISTRESS SYNDROME; DRUG HALF LIFE; EVIDENCE BASED PRACTICE; FUNCTIONAL STATUS; HUMAN; INCIDENCE; LIFESTYLE; MOTOR DYSFUNCTION; NAUSEA; NOSE CONGESTION; ORTHOSTATIC HYPOTENSION; PREVALENCE; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; REVIEW; SLEEP; UNSPECIFIED SIDE EFFECT;

EID: 33745902495     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/nedt.2006.2.2.155     Document Type: Review

References (55)

1. Abetz L, Allen R, Follet A, et al. 2004. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther, 26:925-35.
2. Allen RP, Earley CJ. 1996. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep, 19:205-13.
3. Allen RP, Kaplan PW, Buchholz DW et al. 1992. Double blinded, placebo controlled comparison of high dose propoxyphene and moderate dose carbidopa/levodopa for the treatment of periodic limb movements of sleep. Sleep Res, 21:166.
4. Allen RP, Earley CJ. 2001. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol, 18:128-47.
5. Allen RP, Picchietti D, Hening WA, et al. 2003. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med, 4:101-19.
6. Appiah-Kubi L, Pal S, Chaudhuri KR. 2002. Restless legs syndrome (RLS), Parkinson's disease and sustained dopaminergic therapy for RLS. Sleep Med, 3(Suppl):S51-55.
7. Appiah-Kubi L, Nisbet A, Burn DJ, et al. 2003. Use and tolerability of cabergoline in young and older people with Parkinson's disease: a multicentre observational study. J Applied Research, 3:356-62.
8. Atlas Task Force of the American Sleep Disorders Association. 1993. Recording and scoring of leg movements. Sleep, 16:748-59.
9. Chaudhuri KR. 2004. Augmentation and rebound. In Chaudhuri KR, Odin P, Olanow CW (eds). Restless legs syndrome. London and New York: Taylor & Francis and Thomson Publishing Services. p 109-12.
10. Chaudhuri KR. 2003. The restless legs syndrome. Time to recognize a very common movement disorder. Prac Neurol, 3:204-13.
11. Chaudhuri KR, Appiah-Kubi L, Trenkwalder C. 2001. Restless legs syndrome. J Neurol Neurosurg Psychiatry, 71:143-6.
12. Chaudhuri KR, Forbes A, Grosset AL, et al. 2004. Diagnosing restless legs syndrome (RLS) in primary care. Curr Med Res Opin, 20: 1785-95.
13. Corrigan MH, Denahan AQ, Wright CE, et al. 2000. Comparison of pramipexole, fluoxetine and placebo in patients with major depression. Depress Anxiety, 11:58-65.
14. Davis BJ, Rajput A, Rajput ML, et al. 2000. A randomized, double blind placebo controlled trial of iron in restless legs syndrome. Eur Neurol, 43:70-5.
15. DeKokker A, Whitehead H, Chaudhuri KR. 2005. Therapeutic strategies in restless legs syndrome. Future Prescriber, 6:5-10.
16. Earley CJ, Yaffee JB, Allen RP. 1998. Randomized, double blind placebo controlled trial of pergolide in restless legs syndrome. Neurology, 51:1599-602.
17. Ekbom KA. 1945. Restless legs syndrome. Acta Med Scand, 158:4-122.
18. Garcia-Borreguero D, Odin P, Serrano C. 2003. Restless legs syndrome and PD: a review of the evidence for a possible association. Neurology, 61(Suppl):S49-55.
19. Goldberg J, Burdick KE, Endick CJ. 2004.Preliminary randomized placebo-controlled trial of pramipexole added to mood stabilizers for treatment resistant bipolar depression. Am J Psychiatry, 161:564-6.
20. Goodman JDS, Brodie C, Ayida GA. 1988. Restless legs syndrome in pregnancy. BMJ, 297:1101-2.
21. Happe S, Sauter C, Klosch G et al. 2003. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology, 48:82-6.
22. Henning W, Allen R, Earley C, et al. 1999. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep, 22:970-99.
23. Jobges M, Odin P, Chaudhuri KR. 2004. Epidemiology. In Chaudhuri KR, Odin P, Olanow CW (eds). Restless legs syndrome. London and New York: Taylor & Francis and Thomson Publishing Services. p 21-36.
24. Kirsch J, Abetz L, Allen R, et al. 2002. The impact of restless legs syndrome (RLS) on quality of life (QoL) [abstract]. Eur J Neurol, 9(Suppl 2):198 [P3136].
25. Lugaresi E, Coccagna G, Tassinari CA, et al. 1965. Polygraphic data on motor phenomena in the restless legs syndrome. Riv Neurol, 35: 550-61.
26. Maniak S, Kabakei K, Pichler I, et al. 2004. Restless legs syndrome (RLS) in a large family (Family LA) with Parkin-associated Parkinson's disease (PD). Mov Disord, 19(Suppl):S354.
27. Montplaisir J, Boucher S, Poirier G, et al. 1997. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord, 12:61-5.
28. Montplaisir J, Denesle R, Petit D. 2000. Pramipexole in the treatment of restless legs syndrome: a follow up study. Eur J Neurol, 7(Suppl 1): S27-31.
29. Montplaisir J, Nicolas A, Denesle R, et al. 1999. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology, 52:938-43.
30. Mrowka M, Chaudhuri KR, Odin P. 2004. Pathophysiology of restless legs syndrome. In Chaudhuri KR, Odin P, Olanow CW (eds). Restless legs syndrome. London and New York: Taylor & Francis and Thomson Publishing Services. p37-48.
31. Oertel W, Stiasny-Kolster K. 2005. Effective treatment of restless legs syndrome (RLS) with pramiexole: results of a 6 week, multi-centre, double blind and placebo controlled study [abstract]. Eur J Neurology, 12(Suppl 2):P2205.
32. O'Keefe ST, Gavin K, Lavan JN. 1994. Iron status and restless legs syndrome in the elderly. Age Ageing, 23:200-3.
33. Okun MS, Fernandez HH, Foote KD. 2005. Deep brain stimulation of the globus pallidus internus treats restless legs associated with dystonia. Mov Disord, 20:500-1.
34. Ondo WG. 2002. Epidemiology of restless legs syndrome. Sleep Med, 3(Suppl):S13-15.
35. Ondo WG. 2005. Methadone for refarctory restless legs syndrome. Mov Disord, 20:345-8.
36. Ondo WG, Vuong KD, Jankovic J. 2002. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol, 59: 421-4.
37. Partinen M, Hirvonen K, Alakuijala A, et al. 2004. Rapid relief from RLS symptoms with pramipexole: results of a large polysomnographic study [abstract]. Neurology, 62(Suppl 5):LBS.002.
38. Reuter I, Ellis CM, Chaudhuri KR. 1999. Nocturnal subcutaneous apomorphine infusion in Parkinson's Disease and restless legs syndrome. Acta Neurol Scand, 100:163-7.
39. Rothdach A J, Trenkwalder C, Haberstock J, et al. 2000. Prevalence and risk factors of RLS in an elderly population. The MEMO study. Neurology, 54:1064-8.
40. Rutkove SB, Matheson JK, Logigian EL. 1996. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve, 19:670-2.
41. Rye DB. 2004. Parkinson's disease and RLS: the dopaminergic bridge. Sleep Med, 5:317-28.
42. Stiasny K, Moller JC, Bodenschartz R, et al. 2002. Rotigotine CDS (Constant Delivery System) in the treatment of moderate to advanced stages of restless legs syndrome - a double blind placebo-controlled study [abstract]. Mov Disord, 17(Suppl 5):S241.
43. Stiasny K, Wetter TC, Trenkwalder C, et al. 2001. Restless legs syndrome and its treatment by dopamine agonists. Parkinsonism and Relat Disord, 7:21-5.
44. Stiasny-Kolster K, Benes H, Peglau I, et al. 2004. Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology, 63: 2272-9.
45. Stiasny-Kolster K, Kohnen R, Schollmayer E, et al. 2004. The Rotigotine Sp 666 Study Group. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double-blind, placebo-controlled pilot study. Mov Disord, 19:1432-8.
46. Symonds CP. 1953. Nocturnal myoclonus. J Neurol Neurosurg Psychiatry, 16:166-71.
47. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. 2004. Therapy with ropinirole; efficacy and tolerability in RLS. TREAT RLS 1 Study Group. J Neurol Neurosurg Psychiatry, 75:92-7.
48. Trenkwalder C, Hundemer HP, Lledo A, et al. PEARLS Study Group. 2004. Efficacy of pergolide intreatment of restless legs syndrome: the PEARLS study. Neurology, 62:1391-7.
49. Tse W, Koller W, Olanow CW. 2004. Restless legs syndrome: differential diagnosis and treatment. In Chaudhuri KR, Odin P, Olanow CW (eds). Restless legs syndrome. London and New York: Taylor & Francis and Thomson Publishing Services. p 85-108.
50. Wagner M, Walters AS, Coleman RG et al. 1996. Randomized double blind study of clonidine in restless legs syndrome. Sleep, 19:52-8
51. Walters AS, Wagner MI, Henning WA et al. 1993. Successful treatment of the idiopathic RLS in a randomized double blind trial of oxycodone versus placebo. Sleep, 16:327-32.
52. Walters AS. 1995. Toward a better definition of restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord, 10:634-42.
53. Walters AS, Ondo WG, Dreykluft T, et al. on behalf of the TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group. 2004. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord, 19:1414-23.
54. Willis T. 1672. De anima brutorum. London: Wells and Scott.
55. Yoakum R. 1994. Night walkers: do your legs seem to have a life of their own? Your torment has a name. Modern Maturity, 55:82-4.